Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Heidelberg Engineering SPECTRALIS OCT Signal to Noise Ratio Effect on Parameter Measurements

NCT04961398 is registered in ClinicalTrials.gov with Heidelberg Engineering GmbH as lead sponsor.

NCT NCT04961398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04961398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Heidelberg Engineering SPECTRALIS OCT Signal to Noise Ratio Effect on Parameter Measurements
Lead sponsor
Heidelberg Engineering GmbH
Phase
Observational
Overall status
Completed
Start date
June 21, 2021
Completion date
June 24, 2021
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

normal eyes